Developer docs
API playgroundTry for free, no card

Search company profiles

BIO-Europe

Full company profile

uuid00r6o9g

Namestring
BIO-Europe
Legal namestring
Informa Connect Limited
Websiteurl
bioeurope.com
Company typeenum
Private
Founded yearint
1995
Descriptiontext

BIO-Europe is Europe's longest-running partnering conference for the global biotechnology and biopharma industry, organized annually by Informa Connect (part of Informa PLC) and held at Koelnmesse in Cologne, Germany. The 32nd edition is scheduled for November 9-11, 2026, with an expected attendance of 6,000+ senior industry leaders from 3,200+ companies spanning 60+ countries. The event's central product is its dense concentration of biopharma decision-makers in one physical venue, operationalized through the proprietary partneringONE digital platform, which allows attendees to search for partners, request meetings, and schedule thousands of targeted one-to-one discussions before and during the three-day event.

The business generates revenue from three streams: delegate registration (with tiered early-bird pricing through July 1), sponsorship and exhibition packages sold to biopharma companies and service providers, and paid company presentation opportunities for biotechs and pharmas seeking visibility with investors and partners. Historically a pure partnering forum, BIO-Europe is repositioning for 2026 as a broader biopharma strategy conference, with seven integrated content tracks covering regulatory, clinical, biomanufacturing, therapeutic insights, ecosystem innovation, and business strategy in addition to traditional dealmaking. The customer base spans biotech and pharmaceutical companies (primary), investors and VC firms (primary), academic researchers and startups (secondary), and industry service providers such as CDMOs and CROs (secondary).

BIO-Europe does not operate as a standalone company; it is an event brand within Informa Connect, the events division of Informa PLC (LSE: INF). The legal entity operating the event is Informa Connect Limited, registered in England and Wales at 5 Howick Place, London SW1P 1WG. There are no independent funding rounds, M&A, or leadership disclosures, as the event is structurally embedded within Informa's global events portfolio.

Short descriptiontext

BIO-Europe is an annual biopharma partnering conference organized by Informa Connect, drawing 5,800+ senior executives from 3,200+ companies across 60+ countries to Cologne for dealmaking, partnership meetings via the partneringONE platform, and strategic programming.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersMunich, Germany
HQ citystring
Munich
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biopharma partnering events, biotechnology industry conferences, pharmaceutical networking conferences, life sciences business development, biotech investment conferences
Industry1 code
1Medical, Scientific & Healthcare Congress Organizers
CodeTHAHACADPrimaryYes
NAICS code1 code
  • Convention and Trade Show Organizers56192
Product category
Biopharma Industry Conferences and Partnering Events
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Event Registration
TypeOne Time License
Description

BIO-Europe generates revenue through delegate registration fees, with early-bird pricing available through July 1 and various registration pass options for attendees.

informaconnect.com
2Sponsorship & Exhibition
TypeSubscription Recurring
Description

Companies can sponsor the event or exhibit, gaining visibility and access to the high-profile attendee base of over 5,800 senior biopharma leaders.

informaconnect.com
3Company Presentations
TypeOne Time License
Description

Presenting company opportunities allow biotech and pharma companies to showcase their technologies and pipeline to the assembled audience of investors and partners.

informaconnect.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure
Pricing details1 tier
1Early-bird registration rate available through July 1
ModelSubscriptionBilling cadenceAnnual
Notes

Early-bird registration rate available only through July 1 for lowest rate

informaconnect.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1partneringONE
Description

Partnering platform used at BIO-Europe for scheduling one-to-one meetings between attendees

informaconnect.com
Core offering1 text field

BIO-Europe organizes and runs an annual three-day partnering conference for the global biotechnology and biopharma industry, most recently held at Koelnmesse in Cologne, Germany on November 9–11, 2026. The event enables more than 5,800 attendees from over 3,200 companies across 60+ countries to hold thousands of one-to-one meetings, supported by the proprietary partneringONE digital platform that allows delegates to search for partners, request meetings, and schedule discussions before and during the event. Sponsorship, exhibition, and company presentation opportunities are sold alongside delegate registration.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • More than half of new business and partnerships are result of meetings at BIO-Europe
+1 more record
Product overview1 text field

BIO-Europe is a single unified conference event organized by Informa Connect, serving as Europe's largest and longest-running partnering conference for the global biotechnology and biopharma industry. The offering consists of the core BIO-Europe annual conference (delivering networking, partnering meetings, and industry content) supplemented by the proprietary partneringONE online platform for scheduling one-to-one meetings. The 2026 edition introduces an expanded program with seven integrated content tracks—The Big Picture, The Business of Biotech, Regulatory Strategies, Therapeutic Insights, Biomanufacturing Strategies, Ecosystem Innovation, and Clinical Strategy—positioning the event as a comprehensive biopharma strategy forum rather than solely a partnering venue.

Product and service2 records
1BIO-Europe Annual Partnering Conference
CategoryBiopharma Industry Conferences and Partnering Events
Description

Europe's largest and longest-running annual partnering conference for the global biotechnology and biopharma industry. The three-day event brings together 5,800+ attendees from 3,200+ companies across 60+ countries to build partnerships, share insights, and explore business opportunities in life sciences, with paid delegate registration, sponsorship and exhibition packages, and paid company presentation opportunities.

2partneringONE Digital Partnering Platform
CategoryDigital Partnering Platform
Description

The proprietary web-based digital partnering platform that allows BIO-Europe attendees to search for potential partners, request meetings, and schedule one-to-one discussions before and during the event, enabling thousands of targeted meetings between companies, investors, and innovators over the three-day conference. Has dedicated resources and upgrade pages on the BIO-Europe website.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

BIO-Europe is organized by Informa Connect, a global leader in delivering events, digital platforms, and networking opportunities for professionals across various industries including life sciences. Informa Connect is part of Informa PLC, operating from 5 Howick Place, London SW1P 1WG, registered in England and Wales.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The largest annual healthcare investment conference globally, held each January in San Francisco. It attracts the same senior biopharma, investor, and BD audience that BIO-Europe targets, and competes for first-look deal flow and senior-executive calendar time.

2BioPharm America
TypeDirect peer
Description

Informa's North American biotech partnering event using the same partneringONE platform as BIO-Europe. It is a sister event targeting US biotech deal-making and a direct competitive/complementary event within Informa's own portfolio.

3Biotech Showcase
TypeDirect peer
Description

An investor and biotech conference held alongside the J.P. Morgan Healthcare Conference. It competes for the same senior biotech and investor audience as BIO-Europe, particularly for early-stage and public-company presenting opportunities.

TypeRegional player
Description

A China-focused biotech partnering conference also using Informa's partneringONE platform. It serves the same biotech partnering mission as BIO-Europe but is geographically targeted at the China/Asia ecosystem.

TypeEmerging player
Description

A major global pharma exhibition covering ingredients, contract services, and biopharma manufacturing. Overlaps with BIO-Europe on biomanufacturing and biopharma BD audiences but is structured as a large-scale trade show rather than a curated partnering event.

6BIO Latin America
TypeRegional player
Description

BIO's Latin American biotech partnering event serving the same biotech-pharma-investor audience as BIO-Europe but in the LATAM region. It is a regional peer with similar structure but different geographic focus.

7BIO International Convention
TypeDirect peer
Description

BIO's flagship global biotech partnering event held annually in the US, drawing tens of thousands of biotech, pharma, and investor attendees. It is the largest direct competitor to BIO-Europe and the other half of the global biotech partnering event duopoly.

8Bio-Europe Spring (historical)
TypeDirect peer
Description

Historically a spring edition of BIO-Europe, organized by the same Informa/EBD Group team. Represents a former complementary event in the same franchise and the most directly comparable peer historically.

TypeEmerging player
Description

A European-based life sciences executive conference and partnering forum that targets C-suite and BD leaders in biotech and pharma. It is a smaller, emerging competitor to BIO-Europe focused on the European mid-market biotech segment.

TypeDirect peer
Description

BIO's Asia-focused biotech partnering conference modeled on BIO-Europe's partneringONE format. It targets the same biotech, pharma, and investor audience but serves Asian markets, making it a regional/seasonal complement to BIO-Europe.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BIO-Europe

Biopharma Industry Conferences and Partnering Eventsbioeurope.com

BIO-Europe is an annual biopharma partnering conference organized by Informa Connect, drawing 5,800+ senior executives from 3,200+ companies across 60+ countries to Cologne for dealmaking, partnership meetings via the partneringONE platform, and strategic programming.

What BIO-Europe does

BIO-Europe is Europe's longest-running partnering conference for the global biotechnology and biopharma industry, organized annually by Informa Connect (part of Informa PLC) and held at Koelnmesse in Cologne, Germany. The 32nd edition is scheduled for November 9-11, 2026, with an expected attendance of 6,000+ senior industry leaders from 3,200+ companies spanning 60+ countries. The event's central product is its dense concentration of biopharma decision-makers in one physical venue, operationalized through the proprietary partneringONE digital platform, which allows attendees to search for partners, request meetings, and schedule thousands of targeted one-to-one discussions before and during the three-day event.

The business generates revenue from three streams: delegate registration (with tiered early-bird pricing through July 1), sponsorship and exhibition packages sold to biopharma companies and service providers, and paid company presentation opportunities for biotechs and pharmas seeking visibility with investors and partners. Historically a pure partnering forum, BIO-Europe is repositioning for 2026 as a broader biopharma strategy conference, with seven integrated content tracks covering regulatory, clinical, biomanufacturing, therapeutic insights, ecosystem innovation, and business strategy in addition to traditional dealmaking. The customer base spans biotech and pharmaceutical companies (primary), investors and VC firms (primary), academic researchers and startups (secondary), and industry service providers such as CDMOs and CROs (secondary).

BIO-Europe does not operate as a standalone company; it is an event brand within Informa Connect, the events division of Informa PLC (LSE: INF). The legal entity operating the event is Informa Connect Limited, registered in England and Wales at 5 Howick Place, London SW1P 1WG. There are no independent funding rounds, M&A, or leadership disclosures, as the event is structurally embedded within Informa's global events portfolio.

BIO-Europe firmographics

Firmographics
Name
BIO-Europe
Legal name
Informa Connect Limited
Website
https://bioeurope.com
Company type
Private
Founded year
1995
Operating status
Operating
Short description
BIO-Europe is an annual biopharma partnering conference organized by Informa Connect, drawing 5,800+ senior executives from 3,200+ companies across 60+ countries to Cologne for dealmaking, partnership meetings via the partneringONE platform, and strategic programming.
Ownership category
akta.pro rank

BIO-Europe industry classification

Industry
Product category
Biopharma Industry Conferences and Partnering Events
NAICS
Convention and Trade Show Organizers (56192)
akta.pro primary industry
Medical, Scientific & Healthcare Congress Organizers (THAHACAD)

Keywords

  • Biopharma partnering events
  • Biotechnology industry conferences
  • Pharmaceutical networking conferences
  • Life sciences business development
  • Biotech investment conferences

Where BIO-Europe is headquartered

Location

Headquarters

HQ city
Munich
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

BIO-Europe business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure

Revenue model

  1. Event Registration: BIO-Europe generates revenue through delegate registration fees, with early-bird pricing available through July 1 and various registration pass options for attendees.
  2. Sponsorship & Exhibition: Companies can sponsor the event or exhibit, gaining visibility and access to the high-profile attendee base of over 5,800 senior biopharma leaders.
  3. Company Presentations: Presenting company opportunities allow biotech and pharma companies to showcase their technologies and pipeline to the assembled audience of investors and partners.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEarly-bird registration rate available through July 1

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

BIO-Europe product offering

Product offering

Core offering

BIO-Europe organizes and runs an annual three-day partnering conference for the global biotechnology and biopharma industry, most recently held at Koelnmesse in Cologne, Germany on November 9–11, 2026. The event enables more than 5,800 attendees from over 3,200 companies across 60+ countries to hold thousands of one-to-one meetings, supported by the proprietary partneringONE digital platform that allows delegates to search for partners, request meetings, and schedule discussions before and during the event. Sponsorship, exhibition, and company presentation opportunities are sold alongside delegate registration.

Product overview

BIO-Europe is a single unified conference event organized by Informa Connect, serving as Europe's largest and longest-running partnering conference for the global biotechnology and biopharma industry. The offering consists of the core BIO-Europe annual conference (delivering networking, partnering meetings, and industry content) supplemented by the proprietary partneringONE online platform for scheduling one-to-one meetings. The 2026 edition introduces an expanded program with seven integrated content tracks—The Big Picture, The Business of Biotech, Regulatory Strategies, Therapeutic Insights, Biomanufacturing Strategies, Ecosystem Innovation, and Clinical Strategy—positioning the event as a comprehensive biopharma strategy forum rather than solely a partnering venue.

Differentiator

Problem solved

Functional benefit

Brands

  • partneringONE: Partnering platform used at BIO-Europe for scheduling one-to-one meetings between attendees

Products and services

  • BIO-Europe Annual Partnering Conference Europe's largest and longest-running annual partnering conference for the global biotechnology and biopharma industry. The three-day event brings together 5,800+ attendees from 3,200+ companies across 60+ countries to build partnerships, share insights, and explore business opportunities in life sciences, with paid delegate registration, sponsorship and exhibition packages, and paid company presentation opportunities.
  • partneringONE Digital Partnering Platform The proprietary web-based digital partnering platform that allows BIO-Europe attendees to search for potential partners, request meetings, and schedule one-to-one discussions before and during the event, enabling thousands of targeted meetings between companies, investors, and innovators over the three-day conference. Has dedicated resources and upgrade pages on the BIO-Europe website.

Quantifiable outcome

  • More than half of new business and partnerships are result of meetings at BIO-Europe
  • +1 more outcomes

Companies that use BIO-Europe

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

BIO-Europe technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

BIO-Europe partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Informa ConnectcoreOthersBIO-Europe is organized by Informa Connect, a global leader in delivering events, digital platforms, and networking opportunities for professionals across various industries including life sciences. Informa Connect is part of Informa PLC, operating from 5 Howick Place, London SW1P 1WG, registered in England and Wales.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

BIO-Europe competitors and assessment

Company assessment

Direct peers

  • J.P. Morgan Healthcare Conference: The largest annual healthcare investment conference globally, held each January in San Francisco. It attracts the same senior biopharma, investor, and BD audience that BIO-Europe targets, and competes for first-look deal flow and senior-executive calendar time.
  • BioPharm America: Informa's North American biotech partnering event using the same partneringONE platform as BIO-Europe. It is a sister event targeting US biotech deal-making and a direct competitive/complementary event within Informa's own portfolio.
  • Biotech Showcase: An investor and biotech conference held alongside the J.P. Morgan Healthcare Conference. It competes for the same senior biotech and investor audience as BIO-Europe, particularly for early-stage and public-company presenting opportunities.
  • BIO International Convention: BIO's flagship global biotech partnering event held annually in the US, drawing tens of thousands of biotech, pharma, and investor attendees. It is the largest direct competitor to BIO-Europe and the other half of the global biotech partnering event duopoly.
  • Bio-Europe Spring (historical): Historically a spring edition of BIO-Europe, organized by the same Informa/EBD Group team. Represents a former complementary event in the same franchise and the most directly comparable peer historically.
  • BIO Asia: BIO's Asia-focused biotech partnering conference modeled on BIO-Europe's partneringONE format. It targets the same biotech, pharma, and investor audience but serves Asian markets, making it a regional/seasonal complement to BIO-Europe.

Regional players

  • ChinaBio Partnering Forum: A China-focused biotech partnering conference also using Informa's partneringONE platform. It serves the same biotech partnering mission as BIO-Europe but is geographically targeted at the China/Asia ecosystem.
  • BIO Latin America: BIO's Latin American biotech partnering event serving the same biotech-pharma-investor audience as BIO-Europe but in the LATAM region. It is a regional peer with similar structure but different geographic focus.

Emerging players

  • CPhI Worldwide: A major global pharma exhibition covering ingredients, contract services, and biopharma manufacturing. Overlaps with BIO-Europe on biomanufacturing and biopharma BD audiences but is structured as a large-scale trade show rather than a curated partnering event.
  • LSX (Lifesciences Executives) Congress: A European-based life sciences executive conference and partnering forum that targets C-suite and BD leaders in biotech and pharma. It is a smaller, emerging competitor to BIO-Europe focused on the European mid-market biotech segment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

BIO-Europe social profiles

Digital presence

BIO-Europe financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BIO-Europe leadership team

Management profile

Number of profiles

BIO-Europe funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BIO-Europe M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIO-Europe

What does BIO-Europe do?

BIO-Europe organizes and runs an annual three-day partnering conference for the global biotechnology and biopharma industry, most recently held at Koelnmesse in Cologne, Germany on November 9–11, 2026. The event enables more than 5,800 attendees from over 3,200 companies across 60+ countries to hold thousands of one-to-one meetings, supported by the proprietary partneringONE digital platform that allows delegates to search for partners, request meetings, and schedule discussions before and during the event. Sponsorship, exhibition, and company presentation opportunities are sold alongside delegate registration.

Is BIO-Europe a public or private company?

BIO-Europe is a private company. It is classified as corporate owned and is currently operating.

When was BIO-Europe founded?

BIO-Europe was founded in 1995.

Where is BIO-Europe based?

BIO-Europe is headquartered in Munich, Germany, in the Europe region.

How does BIO-Europe make money?

Three revenue lines are on record. Event Registration is the primary driver. The others are sponsorship & Exhibition and company Presentations.

Who are BIO-Europe's main competitors?

Direct peers on record are J.P. Morgan Healthcare Conference, BioPharm America, Biotech Showcase, BIO International Convention, Bio-Europe Spring (historical) and BIO Asia. Regional players are ChinaBio Partnering Forum and BIO Latin America. Emerging players are CPhI Worldwide and LSX (Lifesciences Executives) Congress.

Does BIO-Europe have an API?

No public API is recorded for BIO-Europe.

What industry is BIO-Europe in?

BIO-Europe's product category is Biopharma Industry Conferences and Partnering Events. Its primary akta.pro industry code is THAHACAD, Medical, Scientific & Healthcare Congress Organizers. Its NAICS code is 56192.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireBIO-Europe unveils renewed vision as the must-attend global biopharma strategy forumBIO-Europe has announced a renewed vision for its 32nd annual conference, scheduled for November 9-11, 2026, in Cologne, Germany, positioning itself as the continent's largest biopharma strategy forum rather than simply a partnering event. The expanded program will feature seven integrated tracks spanning regulatory, clinical, and manufacturing strategy, alongside traditional dealmaking, with expectations of drawing over 6,000 senior industry leaders from Europe, North America, and Asia. The evolution reflects the biopharma industry's need for more connected, cross-functional decision-making amid increasing complexity across regulation, policy, and financing.BioSpaceBIO-Europe unveils renewed vision as the must-attend global biopharma strategy forumBIO-Europe announced its 2026 conference in Cologne will evolve into the continent's largest biopharma strategy forum, convening the full C-suite. The program expands to seven integrated tracks and plenary sessions on regulatory, clinical, and manufacturing strategy. The event aims to shape the industry's strategic direction beyond partnering.GlobeNewswireBIO-Europe Spring® 2026 Charts the Future of Life Sciences from Lisbon’s ShoresBIO-Europe Spring 2026 will be held in Lisbon from March 23–25, with a digital experience March 31–April 1, marking the first time BIO-Europe Spring and LSX Europe meet back-to-back. The event expects over 3,700 international stakeholders and 20,000 partnering meetings, with discounted rates available until March 20.Labiotech.euLisbon is calling: the BIO-Europe Startup Spotlight returns in March 2026German biotech startup Fusix Biotech won the 2025 BIO-Europe Startup Spotlight pitch competition in Vienna with their InFUSE platform, which uses chimeric fusogenic oncolytic viruses derived from veterinary virus backbones for treating solid tumors. The company is currently fundraising to scale up manufacturing and complete IND toxicology studies, with plans to begin first-in-human trials in 2027. Applications are now open for the next edition of the competition, which will be held in Lisbon in March 2026.GlobeNewswireSOTIO to Present at BIO-Europe Digital 2020SOTIO announced that Jens Hennecke, chief business officer, will present at BIO-Europe Digital 2020, held Oct 26-29 in a fully digital format. The presentation will be available on demand on the Bio Europe website for registered attendees. The event is expected to bring together over 3,000 executives from more than 1,400 life sciences companies.GlobeNewswireCapricor Therapeutics to Provide Corporate Update at BIO-Europe Conference on Nov. 6Capricor Therapeutics will present its cell and exosome-based therapies for Duchenne muscular dystrophy and other rare diseases at BIO-Europe in Copenhagen on Nov. 6. The presentation will be given by CFO A.J. Bergmann, covering the company's lead candidate CAP-1002 and its cell-free candidate CAP-2003.PR NewswireTrigemina to Present at the BIO-Europe Spring 2016 ConferenceTrigemina, Inc., a biopharmaceutical company developing nose-to-brain therapies for neurological disorders, announced it will present at the BIO-Europe Spring 2016 Conference in Stockholm, Sweden on April 5, 2016. The presentation by CEO Charles Yeomans will discuss the company's Phase 2 trial results for TI-001, a product candidate for migraine headache prophylaxis, which showed promising results and will support a planned Phase 2b study expected to begin later in 2016. The conference is an annual partnering event for the biotech, pharmaceutical, and finance industries.PR NewswireStart-up Slam: 18 junge Biotech-Unternehmen werden in einer Sondersitzung auf der BIO‑Europe Spring® 2016 vorgestelltEBD Group is organizing a 'Start-up Slam: Sweden' session at BIO-Europe Spring 2016 in Stockholm, where 18 young biotech companies will present their technologies to investors and business development executives. The event is supported by Johnson & Johnson Innovation Centre and aims to help these startups refine their pitches and secure partnerships.GlobeNewswirePluristem to Participate in Three European Life Sciences Conferences in NovemberPluristem Therapeutics executives will attend three European life sciences conferences in November, including BioEurope, ARM's investor day, and Berlin Dialogue. The company also reported its PLX-PAD cells were selected for the European Medicines Agency's Adaptive Pathways Project and expanded a collaboration with Charité.